Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 11:29 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2665–2688 of 21,056 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: PreDiabetes, Aging
Interventions: KH-1, Placebo; Dietary Supplement · Other
Lead sponsor: Kalin Health, LLC; Industry
Eligibility: 50 Years and older
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Cancer of Head and Neck
Interventions: Not listed
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2022
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: SARS-CoV2 Infection
Interventions: Culturally Targeted SARS-CoV-2 Communication, General SARS-CoV-2 Communication; Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: 18 Years and older
Enrollment: 666 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Flint, Michigan

Conditions: Sepsis
Interventions: Muscle stimulation with Niveus medical stimulator, measurement of maximal isometric twitch strength, Muscle Biopsy, Muscle Biopsy Medication: Lidocaine, Muscle Biopsy Medication: Versed, Muscle Biopsy Medication: Fentanyl, Blood and Urine Sampling, ineffective muscle stimulation; Device · Procedure · Drug + 1 more
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Pain Associated With Fibromyalgia
Interventions: DS-5565, Pregabalin, Placebo tablet, Placebo capsule; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years and older
Enrollment: 1,270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 86
States / cities: Mobile, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 81 more

Conditions: Cancer
Interventions: Acupuncture and questionnaires, placebo acupuncture; Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years to 64 Years
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2011
U.S. locations: 2
States / cities: Basking Ridge, New Jersey • New York, New York

Conditions: Depression
Interventions: transcranial direct current stimulation, iomed phoresor transcranial direct current stimulation; Device
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: TBI (Traumatic Brain Injury), Brain Concussion, Clinical Trial, Rehabilitation, Cognition, Psychosocial Functioning, Walking, Vision, Ocular, Mobile Application, Saliva, microRNA, Exercise
Interventions: Brain & Walk Exercise Every Day (BraW-Day); Behavioral
Lead sponsor: University of Nevada, Las Vegas; Other
Eligibility: 18 Years to 40 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Agitation, Delirium
Interventions: BXCL501, Placebo film; Drug
Lead sponsor: BioXcel Therapeutics Inc; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Plantar Fasciitis, Chronic, Heel Pain Syndrome, Fat Pad Syndrome
Interventions: PopSole™ Offloading Device; Device
Lead sponsor: Jeffrey A. Gusenoff, MD; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Brain Injuries, Post-Traumatic Headache
Interventions: Amitriptyline; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 60 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Healthy Participants
Interventions: No Practice Effects (NPE) cognitive battery, and Miami Computerized Functional Assessment Scale (CFAS), Preclinical Alzheimer's Cognitive Composite (PACC), Alzheimer's Disease Assessment Scale-Cognitive Scale (ADAS-Cog), and Functional Assessment Questionnaire (FAQ); Other
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 60 Years to 85 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 4
States / cities: Los Angeles, California • Miami, Florida • Manhasset, New York + 1 more

Conditions: Healthy Participants, Pharmacokinetic Study
Interventions: AGA2118; Drug
Lead sponsor: Angitia Incorporated Limited; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Glendale, California

Conditions: Pancreatic Cancer
Interventions: Proton Beam Radiation, Capecitabine; Procedure · Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2017
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Macular Degeneration
Interventions: BI 754132; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 50 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 8
States / cities: Beverly Hills, California • Pensacola, Florida • Winter Haven, Florida + 5 more

Conditions: Lewy Body Dementia (LBD), Alzheimer Dementia (AD)
Interventions: C-11 ER-176, Blood Test; Drug · Diagnostic Test
Lead sponsor: Val Lowe; Other
Eligibility: 60 Years and older
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2030
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Tobacco Use Disorder
Interventions: Bupropion and NRT; Drug
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years and older
Enrollment: 407 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2009
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Hypertension
Interventions: iHealth Wireless Blood Pressure Monitor; Device
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Focus: Assess Post Infusion Viability of S303 RBCs
Interventions: S303 Red Blood Cells (RBCs), Conventional, untreated Red Blood Cells (RBCs); Biological
Lead sponsor: Cerus Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 2
States / cities: Cincinnati, Ohio • Milwaukee, Wisconsin

Conditions: Systemic Lupus Erythematosus
Interventions: Peripheral lab draws; Other
Lead sponsor: The Center for Rheumatic Disease, Allergy, & Immunology; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2013
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Type 1 Diabetes Mellitus, Hypoglycemia
Interventions: Allogeneic Islets of Langerhans, Everolimus, anti-thymocyte globulin, Cyclosporine; Biological · Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 65 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Myelopathy, Compressive, Radiculopathy, Cervical, C5 Palsy
Interventions: Bilateral Cervical Keyhole Foraminotomy, Cervical Decompression; Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 480 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Anxiety Sensitivity, Functional Impairment
Interventions: Brief Enhanced Anxiety Sensitivity Treatment; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Canandaigua, New York

Conditions: Postmenopausal Osteoporosis
Interventions: Teriparatide 40-mcg subcutaneous injection, Denosumab Injection, Alendronate Oral Tablet; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 45 Years and older · Female only
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Safety and Efficacy of KH-1 for Stimulating Autophagy in Non-diabetic Adults With Elevated Blood Glucose Concentration

Hyperbaric Oxygen and Its Effect on Radiation Induced Long Term Side Effects

Culturally-Targeted COVID-19 Communication and SARS-CoV-2 Antibody Testing Evaluation and Uptake

Project 4B: Lower Extremity Strength Training in ICU Patients

Treatment of Pain Associated With Fibromyalgia

Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial

Treating Depression With Transcranial Direct Current Stimulation (tDCS)

Dual-Task Exercise for Mild Traumatic Brain Injury (mTBI)

Study of BXCL501 In Agitation Associated With Delirium in ICU Patients

Validation of a Novel Foot Offloading Device

Amitriptyline to Prevent Headache After Traumatic Brain Injury

Development of Novel Measures for Alzheimer's Disease Prevention Trials

An Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS)

Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer

A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy

Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias

Maintaining Abstinence in Chronic Cigarette Smokers - 1

Assessing Blood Pressure Remotely in Childhood Cancer Survivors

A Study to Assess the Recovery and Lifespan of Radiolabeled Autologous S303 Treated Red Blood Cells

Estrogen and Gender Biased Autoimmunity

Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation

Can Prophylactic Foraminotomy Prevent C5 Palsy

BEAST: A Pilot Trial

Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption